Search Results

Your search for Meg O’Brien, PhD,Meg O’Brien, PhD matches 2 pages

Showing 1 - 2

By Meg O’Brien, PhD / March 1 2012

Inefficient Markets Impede Cancer Pain Relief

The potent analgesic property of morphine was first isolated in 1804, and after more than 2 centuries morphine is still the gold standard for moderate to severe pain. It is relatively easy to produce, and compared to most pharmaceuticals, morphine is dirt-cheap. Therein lies the cruel conundrum:...

global cancer care

pain management

palliative care

By Ronald Piana / May 15 2012

Untreated Cancer Pain Remains a Significant Global Problem

“Physicians are afraid of morphine … Doctors [in Kenya] are so used to patients dying in pain … they think that this is how you must die. They are suspicious if you don’t die this way — [and feel] that you died prematurely.” —Human Rights Watch interview with Dr. John Weru of Nairobi Hospice,...

Nov

Today In Oncology

Search Results

Your search for Meg O’Brien, PhD,Meg O’Brien, PhD matches 2 pages

Inefficient Markets Impede Cancer Pain Relief

Untreated Cancer Pain Remains a Significant Global Problem

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC